We accompany you throughout the pre-clinical phase

We assist in formulating prototypes and scaling up for GLP toxicology studies. We thrive on complex projects, including novel drug delivery platforms and new chemical entities (NCEs), where tailored processes are developed to progress through development pipelines effectively. Our in-house capabilities ensure rigorous quality assurance throughout manufacturing, adhering to regulatory standards to prepare your product for clinical trials seamlessly.

Our CDMO services extend beyond formulation and manufacturing to include comprehensive support from concept to commercialization. We leverage a data-driven approach in formulation development, focusing on maximizing bioavailability, controlling release rates, and enhancing stability for even the most challenging APIs. With dedicated GMP manufacturing facilities for various dosage forms, supported by in-house analytical services and ICH-compliant stability programs, we facilitate a smooth transition from pre-clinical activities through clinical validation to commercial manufacturing.

Agno Pharma’s commitment to excellence in pre-clinical drug product manufacturing is underscored by our flexible infrastructure, skilled team, and advanced facilities. We are equipped to handle diverse formulation challenges and provide robust support at every stage of your product’s development journey. Whether you are navigating early-stage complexities or preparing for commercial production, we offer tailored solutions to meet your specific needs, ensuring your drug product progresses efficiently and effectively toward market readiness.